• Rivastigmine is an Acetylcholinesterase inhibitor for the treatment of:
ØMild to moderate Alzheimer’s disease.
ØMild to moderate Dementia associated with Parkinson’s disease.

•Rivamash is available in the market 4 concentrations:
ØRivamash 1.5 mg
ØRivamash 3 mg
ØRivamash 4.5 mg
ØRivamash 6 mg